Cardio Diagnostics Holdings, Inc. [Rocket]

Overview

Cardio Diagnostics Holdings, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
10/12/2023	PRE 14A	Form PRE 14A - Other preliminary proxy statements:
10/04/2023	4	Lau Stanley K. (Director) has filed a Form 4 on Cardio Diagnostics Holdings, Inc.
10/04/2023	4/A	Levy Oded (Director) has filed a Form 4 on Cardio Diagnostics Holdings, Inc.
10/04/2023	4/A	Intrater James (Director) has filed a Form 4 on Cardio Diagnostics Holdings, Inc.
10/04/2023	4/A	Sim Brandon (Director) has filed a Form 4 on Cardio Diagnostics Holdings, Inc.
10/03/2023	4	Levy Oded (Director) has filed a Form 4 on Cardio Diagnostics Holdings, Inc.
10/03/2023	4	Intrater James (Director) has filed a Form 4 on Cardio Diagnostics Holdings, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21
Revenues	0.0	0.0
Revenue growth	5.4%
Cost of goods sold	0.0	0.0
Gross profit	0.0	0.0
Gross margin	100.0%	100.0%
Sales and marketing	0.1	0.1
Research and development	0.0	0.0
General and administrative	4.4	0.5
EBITA	-4.6	-0.6
EBITA margin	-488945.8%	-67086.3%
Amortization of intangibles	0.0	0.0
EBIT	-4.7	-0.6
EBIT margin	-490630.0%	-68862.2%
Pre-tax income	-4.7	-0.6
Income taxes	0.0	0.0
Tax rate	0.0%	0.0%
Net income	-4.7	-0.6
Net margin	-490630.0%	-68862.2%

Diluted EPS	($1.51)	($0.53)
Shares outstanding (diluted)	3.1	1.2

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.